Genmab A/S (GNMSF)
300.00
-8.00
(-2.60%)
USD |
OTCM |
Feb 11, 09:53
Genmab Market Cap : 18.48B for Feb. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascendis Pharma A/S | 13.51B |
| Zealand Pharma A/S | 4.487B |
| Bavarian Nordic A/S | 2.309B |
| ALK-Abello A/S | 7.932B |
Market Cap Related Metrics
| PE Ratio | 12.76 |
| PS Ratio | 5.264 |
| PEG Ratio | 0.1010 |
| Price to Book Value | 3.213 |
| Price to Free Cash Flow | 15.46 |
| Price | 300.00 |
| Earnings Yield | 7.83% |
| PEGY Ratio | 0.1010 |
| Operating PE Ratio | 14.28 |
| Normalized PE Ratio | 12.70 |